You are here

Trelegy Ellipta

FTC crackdown on ‘bogus’ patents hits Novo’s Ozempic, GSK’s Trelegy Ellipta

Medical Marketing and Media

Fri, 05/3/24 - 11:10 am

Trelegy Ellipta

Theravance gets a fresh start

EP Vantage

Thu, 07/14/22 - 10:50 am

Trelegy Ellipta

FDA approves Trelegy Ellipta as once-daily single inhaler triple therapy for asthma and COPD

Pharmaceutical Business Review

Thu, 09/10/20 - 10:52 am

Trelegy Ellipta

FDA's Advisory Committee to Review Claims That GlaxoSmithKline's Trelegy Ellipta Reduces Mortality

Motley Fool

Fri, 02/21/20 - 11:53 pm

advisory panels

Trelegy Ellipta

GlaxoSmithKline leans on respiratory franchise with Trelegy share-grab

Fierce Pharma

Wed, 10/30/19 - 11:07 pm

Trelegy Ellipta

GSK, Innoviva file sNDA to seek US approval for Trelegy Ellipta in asthma

Pharmaceutical Business Review

Fri, 10/4/19 - 09:59 am

Trelegy Ellipta

With latest data, can AstraZeneca's COPD triple combo rival Glaxo's Trelegy?

Fierce Pharma

Mon, 09/17/18 - 12:13 pm

Trelegy Ellipta

GSK's Trelegy Ellipta Gains New Indication in the US for the Treatment of Patients With COPD

CP Wire

Wed, 04/25/18 - 09:34 am

Trelegy Ellipta

GSK's Trelegy Ellipta Gains New Indication in the US for the Treatment of Patients With COPD

Tue, 04/24/18 - 02:26 pm

GlaxoSmithKline

Trelegy Ellipta

GSK, Innoviva seek expanded label for triple inhaler

Drug Delivery Business News

Mon, 11/27/17 - 09:12 am

Trelegy Ellipta

GSK, Innoviva seek to expand scope of Trelegy Ellipta

Pharma Times

Fri, 11/24/17 - 09:34 am

Trelegy Ellipta

With Advair copies looming, GSK keeps focus on new drugs

Biopharma Dive

Wed, 10/25/17 - 10:12 pm

Trelegy Ellipta

GlaxoSmithKline, needing a sales surge, wins FDA nod for $1B-plus prospect Trelegy

Fierce Pharma

Tue, 09/19/17 - 10:21 pm

Trelegy Ellipta

GSK’s triple-med COPD inhaler wins recommendation for approval in EU

Drug Delivery Business News

Fri, 09/15/17 - 09:13 am

Trelegy Ellipta